Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in NEUROCRINE BIOSCIENCES INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 571,719 shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $75.3M as of 2026-Q1. The position was decreased (-20.9% shares). NBIX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$75.3M
Current Shares
571,719
Total Value Change
-$50.2M
Total Shares Change
-340,345
Other major holders of NBIX: BNP PARIBAS FINANCIAL MARKETS, DnB Asset Management AS
Decreased |
| 571,719 |
-20.9% |
| $75.3M |
| 0.0% |
| $131.14 |
0 |
| 2025-Q4 | Decreased | 722,476 | -5.6% | $102.5M | 0.0% | $140.95 | 0 |
| 2025-Q3 | Decreased | 765,237 | -44.9% | $107.4M | 0.0% | $140.27 | 0 |
| 2025-Q2 | Increased | 1.4M | +19.7% | $174.4M | 0.0% | $125.42 | 36 |
| 2025-Q1 | Increased | 1.2M | +8.3% | $128.2M | 0.0% | $113.16 | 33 |
| 2024-Q4 | Increased | 1.1M | +19.7% | $146.1M | 0.0% | $137.06 | 36 |
| 2024-Q3 | Decreased | 894,217 | -2.0% | $103M | 0.0% | $115.06 | 0 |
| 2024-Q2 | Increased | 912,064 | +52.2% | $125.6M | 0.0% | $137.67 | 42 |